Consistent with our results, we found that PEDF might stimulate the progression of ESCC via the MAPK/ERK pathway because PEDF can increase the expression of phosphorylated ERK1/2 in esophageal carcinoma cells. This evidence concerns the gene SERPINF1 and esophageal squamous cell carcinoma.